T1	Intervention 471 609	efficacy and safety of ebrotidine, administered in four dosages as a single evening dose versus placebo in the treatment of duodenal ulcer
T2	Intervention 772 849	5 groups: placebo, 200 mg, 400 mg, 600 mg and 800 mg of ebrotidine once daily
